Showing results (171-180 of 395) with videos related to

Sort By:
Pageof 40
Blood|March 15, 1995
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemiasHartmut Döhner, Konstanze Fischer, Martin Bentz, et al.
Plos One|September 7, 2013
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemiaMaria Göbel, Lewin Eisele, Michael Möllmann, et al.
Blood|July 10, 2025
A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLLMin Guo, Tugba Memis, Alena Sophie Ehrmann, et al.
European Journal of Haematology|August 1, 2024
Comparison of R-CHOP-14 and R-mini-CHOP in older adults with diffuse large B-cell lymphoma-A retrospective multicenter cohort studyZelal Guel Dilbaz, Sophy Denker, Carla Ankermann, et al.
Blood|July 4, 2013
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSGAndrea Schnaiter, Peter Paschka, Marianna Rossi, et al.
Leukemia|May 12, 2018
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN studyStephan Stilgenbauer, Veronique Leblond, Robin Foà, et al.
Cellular & Molecular Biology Letters|July 3, 2024
Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasionJunnan Liu, Xue Wang, Wencheng Jiang, et al.
Blood|July 5, 2003
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcomeDirk Kienle, Alexander Kröber, Tiemo Katzenberger, et al.
Haematologica|March 28, 2008
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlationsSandrine Sander, Lars Bullinger, Elke Leupolt, et al.
Cell Death & Disease|July 3, 2024
Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylationStefanie Enzenmüller, Alexandra Niedermayer, Felix Seyfried, et al.
Pageof 40